Clinical Data On Molecular Imaging Of Breast Cancer Metastases Using Anti-HER2 Affibody® Molecules

Affibody is pleased to announce that clinical imaging data using anti-HER2 Affibody® molecules have been presented at the 53rd Annual Meeting of the Society of Nuclear Medicine in San Diego, USA (3-7 June 2006).